Kim Jang-sung Reappointed as Director of Korea Research Institute of Bioscience and Biotechnology

[Asia Economy Reporter Kim Bong-su] The National Science and Technology Council (NST) reappointed Kim Jang-sung, the current president of the Korea Research Institute of Bioscience and Biotechnology (KRIBB), as the next president at the 156th extraordinary board meeting held on the 13th at the Seoul Science and Technology Center.

President Kim succeeded in his reappointment by receiving an excellent rating in the institution operation evaluation during his three-year tenure. This reappointment is the second consecutive term since the launch of NST and the first since the easing of reappointment criteria in October last year. In 2017, former president Lee Byung-kwon of the Korea Institute of Science and Technology (KIST) was reappointed. According to NST, the Enforcement Decree of the "Act on the Establishment, Operation, and Fostering of Government-Funded Research Institutes in the Science and Technology Field" allows reappointment if the evaluation results receive an excellent grade or higher based on the president's management innovation.

President Kim's second term will be three years starting from the 17th. NST explained, "During his tenure, he promptly allocated budget and personnel to respond to COVID-19, actively supporting companies related to vaccines, diagnostic kits, and therapeutics, and operated the full-cycle startup support platform 'KRIBB Bio Startup Booster' to promote the establishment of technology-innovative venture companies," adding, "He was reappointed in recognition of his achievements over the three years, including the establishment and operation of an integrated information system to support research immersion, which was selected as an excellent case for reducing administrative burdens on researchers."

This content was produced with the assistance of AI translation services.